Boostimmune

Boostimmune is a biotechnology company focused on new drug development, researching and developing immunooncology drugs such as MDSC to suppress the immune effects on cancer cells within the tumor's immune microenvironment, enabling clients to increase the frequency and activity of T cells to ultimately kill cancer cells.